Fresenius Medical Care AG & Co. (NYSE:FMS) released its quarterly earnings data on Thursday. The company reported $0.79 EPS for the quarter, beating the consensus estimate of $0.43 by $0.36, Analyst Ratings Net reports. The business earned $4.20 billion during the quarter, compared to analysts’ expectations of $4.13 billion. The company’s quarterly revenue was up 15.0% on a year-over-year basis.

Fresenius Medical Care AG & Co. (NYSE:FMS) traded down 4.87% on Thursday, reaching $41.06. The company had a trading volume of 358,442 shares. Fresenius Medical Care AG & Co. has a 12 month low of $32.40 and a 12 month high of $44.34. The stock has a 50 day moving average of $42.66 and a 200 day moving average of $41.17. The firm has a market capitalization of $24.96 billion and a PE ratio of 23.75.

Separately, Commerzbank AG downgraded Fresenius Medical Care AG & Co. to a “hold” rating in a research note on Friday, May 29th. Six research analysts have rated the stock with a hold rating and four have given a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus target price of $37.03.

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) is a kidney dialysis company. The Company provides dialysis care services related to the dialysis treatment a patient receives with end-stage renal disease (ESRD), as well as other health care services. FMC AG & CO. KGAA also provides dialysis products for the treatment of ESRD, which includes manufacturing and distributing products, such as hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. The Company’s health care services, referred to as care coordination services, include pharmacy services, vascular, cardiovascular and endovascular specialty services, non-dialysis laboratory testing services, physician services, hospitalist and intensivist services, health plan services and urgent care services. The Company also offers a range of dialysis drugs.

Receive News & Ratings for Fresenius Medical Care AG & Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. and related companies with MarketBeat.com's FREE daily email newsletter.

...